Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	106.1	89.14	60.08	127.68	59.25	100.85
Short-Term Investments	208.39	231.43	215.77	205.61	235.61	71.94
Cash & Short-Term Investments	314.49	320.57	275.85	333.29	294.86	172.79
Cash Growth	56.31%	16.21%	-17.23%	13.04%	70.64%	-40.92%
Receivables	17.83	18.51	14.87	6.22	1.03	-
Inventory	19.32	18.74	8.62	2.92	0.11	-
Other Current Assets	-	16.38	8.93	11.81	12.4	8.88
Total Current Assets	369.29	374.2	308.27	354.24	308.39	181.67
Property, Plant & Equipment	3.83	4.11	2.12	3.38	4.34	5
Other Intangible Assets	5.96	6.17	7.03	7.88	4.66	-
Long-Term Deferred Charges	-	6.21	12.59	-	-	-
Other Long-Term Assets	7.61	1.58	2.73	16.98	12.14	0.4
Total Assets	386.69	392.27	332.75	382.48	329.52	187.07
Accounts Payable	11.91	12.33	4.89	4.8	5.74	4.9
Accrued Expenses	53.51	58.31	42.85	30.48	29.26	12.56
Current Portion of Long-Term Debt	1.59	1.54	-	-	-	-
Current Portion of Leases	0.22	-	0.77	0.68	0.61	0.54
Current Unearned Revenue	-	1.29	1.29	1.43	7	-
Other Current Liabilities	44.58	42.05	5.41	2.42	0.83	-
Total Current Liabilities	111.82	115.52	55.2	39.81	43.43	17.99
Long-Term Debt	107.93	108.27	106.14	75.81	-	-
Long-Term Leases	3.84	3.94	0.49	1.26	1.95	2.55
Other Long-Term Liabilities	-	-	1.15	1.34	-	-
Total Liabilities	223.6	227.72	162.99	118.22	45.37	20.55
Common Stock	0.06	0.06	0.06	0.06	0.05	0.04
Additional Paid-In Capital	1,224	1,177	1,064	974.36	813.04	625.76
Retained Earnings	-1,205	-1,155	-894.74	-710.06	-528.94	-459.33
Comprehensive Income & Other	-0.05	-0.04	0.13	-0.09	-0	0.05
Total Common Equity	18.95	21.73	169.76	264.26	284.15	166.53
Shareholders' Equity	163.09	164.55	169.76	264.26	284.15	166.53
Total Liabilities & Equity	386.69	392.27	332.75	382.48	329.52	187.07
Total Debt	113.59	113.75	107.4	77.75	2.55	3.09
Net Cash (Debt)	200.9	206.82	168.44	255.53	292.3	169.71
Net Cash Growth	116.60%	22.78%	-34.08%	-12.58%	72.24%	-41.26%
Net Cash Per Share	3.25	3.39	2.92	4.90	5.89	3.85
Filing Date Shares Outstanding	63.62	63.22	60.14	56.75	50.33	50.18
Total Common Shares Outstanding	63.49	62.39	59.43	56.61	50.28	44.24
Working Capital	257.47	258.68	253.07	314.43	264.96	163.67
Book Value Per Share	0.30	0.35	2.86	4.67	5.65	3.76
Tangible Book Value	12.99	15.56	162.73	256.38	279.49	166.53
Tangible Book Value Per Share	0.20	0.25	2.74	4.53	5.56	3.76
Machinery	-	2.69	2.7	2.65	2.37	1.93
Leasehold Improvements	-	2.71	2.71	2.71	2.71	2.71

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q